What Bubble? JPMORGAN Says AI Capex Boom Pays Now, So Far
JPMORGAN Global Research says the AI-related capital spend is not a fleeting hype cycle but a profitable buildout. Th...
This intro points out equity indices that qualify as total return and explains how dividends affect performance reporting.
24,588 articlesJPMORGAN Global Research says the AI-related capital spend is not a fleeting hype cycle but a profitable buildout. Th...
A clear, practical look at Bowhead Specialty's Q4 2025 earnings transcript. Learn what the numbers mean, which metric...
A rising tax trap could convert a $260,000 401(k) deferral into a looming $700K RMD burden. The piece explains the ma...
Could SpaceX become a defining winner in a new era of commercial space? This guide breaks down how buying SpaceX toda...
As investors look toward talen (tln) 2025 earnings, the Q4 transcript becomes the compass for revenue, margins, and g...
Hedge fund veteran Michael Burry has added stakes in a high-dividend pharma name and a leading oilfield services comp...
Could a Palantir competitor deliver the kind of upside that fans of AI software chase? This article breaks down the c...
In 2026, Nike faces a pivotal test beyond revenue growth. This article explains why nike's most important question ce...
Berkshire Hathaway's latest moves under Greg Abel show a shift toward stability with Apple while betting bigger on Al...
Two financial plans, one patient retiree, and a surprising reframe: treating Social Security as a bond changes how a ...
Policy clarity clears the path for road ahead build-to-rent projects, lifting investor confidence. Still, the pace of...
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...